The FTC’s five Commissioners issue statements on a range of important topics to engage with the public and express the views of the Commission as well as their own individual views.
Displaying 1 - 20 of 987
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak In the Matter of US Anesthesia Partners/Guardian Anesthesia
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Matter Number
201 0031
Dissenting Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Surveillance Pricing 6(b) Staff Research Summaries
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Matter Number
P246202
Dissenting Statement of Commissioner Melissa Holyoak Joined by Commissioner Andrew N. Ferguson In the Matter of ExxonMobil/Pioneer Resources
Date
By
Melissa Holyoak, Commissioner;
Andrew N. Ferguson, Chairman
Matter Number
241 0004
Concurring and Dissenting Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the FTC Staff Report on AI Partnerships & Investments 6(b) Study
Date
By
Andrew N. Ferguson, Chairman;
Melissa Holyoak, Commissioner
Matter Number
P246201
Statement of Chair Lina M. Khan In the Matter of Caremark/ESI/Optum
Date
By
Lina M. Khan, Commissioner
Matter Number
241 0005
File
Statement of Chair Lina M. Khan In the Matter of Exxon Mobil Corporation
Date
By
Lina M. Khan, Commissioner
Matter Number
241 0004
Concurring and Dissenting Statement of Commissioner Melissa Holyoak Joined by Commissioner Andrew N. Ferguson In Matter of AI Partnerships and Investments 6(b) Study
Date
By
Melissa Holyoak, Commissioner;
Andrew N. Ferguson, Chairman
Matter Number
P246201
Statement of Chair Lina M. Khan Regarding the Final Rule Amending the Children’s Online Privacy Protection Rule
Date
By
Lina M. Khan, Commissioner
Matter Number
P195404
Concurring Statement of Commissioner Andrew N. Ferguson COPPA Rule Amendments
Date
By
Andrew N. Ferguson, Chairman
Matter Number
P195404